Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 67806-1-Ig - Provider product page

- Provider
- Proteintech Group
- Product name
- PKMYT1 antibody
- Antibody type
- Monoclonal
- Description
- PKMYT1 antibody (Cat. #67806-1-Ig) is a mouse monoclonal antibody that shows reactivity with Human, mouse, rat and has been validated for the following applications: IHC, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Mouse
- Conjugate
- Unconjugated
- Isotype
- IgG
- Antibody clone number
- 1D12D3
- Vial size
- 20ul, 150ul
Submitted references PKMYT1 kinase ameliorates cisplatin sensitivity in osteosarcoma.
Meisoindigo Acts as a Molecular Glue to Target PKMYT1 for Degradation in Chronic Myeloid Leukemia Therapy.
Arf1 GTPase Regulates Golgi-Dependent G2/M Transition and Spindle Organization in Oocyte Meiosis.
ELF3 promotes gemcitabine resistance through PKMYT1/CDK1 signaling pathway in gallbladder cancer.
Liu B, Li W, Zhang W, Feng C, Wan L, He S, Xu R, Fu Z, Liu Z, Xu H, Jin X, Tu C, Li Z
Signal transduction and targeted therapy 2025 May 21;10(1):165
Signal transduction and targeted therapy 2025 May 21;10(1):165
Meisoindigo Acts as a Molecular Glue to Target PKMYT1 for Degradation in Chronic Myeloid Leukemia Therapy.
Zhang ZX, Li SY, Li FF, Shi QY, Tan CY, Wang XJ, Li M, Liu YB, Jin J, Li Y, Yu SS
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2025 Jun;12(21):e2413676
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2025 Jun;12(21):e2413676
Arf1 GTPase Regulates Golgi-Dependent G2/M Transition and Spindle Organization in Oocyte Meiosis.
Zhang KH, Zou YJ, Shan MM, Pan ZN, Ju JQ, Liu JC, Ji YM, Sun SC
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2024 Jan;11(4):e2303009
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2024 Jan;11(4):e2303009
ELF3 promotes gemcitabine resistance through PKMYT1/CDK1 signaling pathway in gallbladder cancer.
Yang L, Wang H, Guo M, He M, Zhang W, Zhan M, Liu Y
Cellular oncology (Dordrecht, Netherlands) 2023 Aug;46(4):1085-1095
Cellular oncology (Dordrecht, Netherlands) 2023 Aug;46(4):1085-1095
No comments: Submit comment
No validations: Submit validation data